Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume

Journal of Physiology

Volumn 578, Issue 1, 2007, Pages 309-314

  Lundby, Carsten ^a,b   Thomsen, Jonas Juhl ^a   Boushel, Robert ^a,c   Koskolou, Maria ^d   Warberg, Jørgen ^e   Calbet, José A L ^a,f   Robach, Paul ^g  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Gina Cody School of Engineering and Computer Science   (Canada)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^g Ecole Nationale de Ski et d'Alpinisme   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; HEMOGLOBIN; IRON; OXYGEN; RECOMBINANT ERYTHROPOIETIN; RENIN;

ADULT; ARTERIAL OXYGEN TENSION; ARTICLE; DOWN REGULATION; DRUG ACTIVITY; ERYTHROCYTE VOLUME; ERYTHROPOIESIS; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PRIORITY JOURNAL; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ALDOSTERONE BLOOD LEVEL; BLOOD VESSEL PARAMETERS; CELL ELONGATION; CONDUCTANCE; CONTROLLED STUDY; HEART OUTPUT; HEMOGLOBIN BLOOD LEVEL; RESTING HEART RATE; SYSTEMIC VASCULAR CONDUCTANCE;

ADULT; ALDOSTERONE; BLOOD PRESSURE; CARDIAC OUTPUT; DOWN-REGULATION; ERYTHROCYTE VOLUME; ERYTHROPOIESIS; ERYTHROPOIETIN, RECOMBINANT; HEMOGLOBINS; HUMANS; MALE; OXYGEN; PLASMA VOLUME; RENIN; VASCULAR RESISTANCE;

EID: 33845796987     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.122689     Document Type: Article

References (17)

1. Berglund B & Ekblom B (1991). Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 229, 125-130.
2. Burge CM & Skinner SL (1995). Determination of hemoglobin mass and blood volume with CO: Evaluation and application of a method. J Appl Physiol 79, 623-631.
3. 2 content?Am J Physiol Regul Integr Comp Physiol 284, R304-R316.
4. 2 extraction during maximal exercise in humans. Am J Physiol Regul Integr Comp Physiol 291, R447-R453.
5. Donnelly SM & Miller JA (2001). Losartan may modulate erythropoietin production. J Renin Angiotensin Aldosterone Syst 2, 255-260.
6. Ehmke H, Just A, Eckardt KU, Persson PB, Bauer C & Kirchheim HR (1995). Modulation of erythropoietin formation by changes in blood volume in conscious dogs. J Physiol 488, 181-191.
7. Ekblom B & Berglund B (1991). Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports 1, 88-93.
8. Freudenthaler SM, Schreeb K, Korner T & Gleiter CH (1999). Angiotensin II increases erythropoietin production in healthy human volunteers. Eur J Clin Invest 29, 816-823.
9. Freudenthaler SM, Lucht I, Schenk T, Brink M & Gleiter CH (2000). Dose-dependent effect of angiotensin II on human erythropoietin production. Eur J Physiol 439, 838-844.
10. Heidenreich S, Rahn KH & Zidek W (1991). Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 39, 259-265.
11. Lundby C, Calbet JA, van Hall G, Saltin B & Sander M (2004). Pulmonary gas exchange at maximal exercise in Danish lowlanders during 8 weeks of acclimatization to 4100 m and in high-altitude Aymara natives. Am J Physiol Regul Integr Comp Physiol 287, R1202-R1208.
12. Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A & Androne AS (2003). Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107, 294-299.
13. Nette RW, Ie EHY, Vletter WB, Krams R, Weimar W & Zietse R (2006). Norepinephrine-induced vasoconstriction results in decreased blood Volume in dialysis patients. Nephrol Dialysis Transplant 21, 1305-1330a.
14. Parisotto R, Wu M, Ashenden MJ, Emslie KR, Gore CJ, Howe C, Kazlauskas R, Sharpe K, Trout GJ & Xie M (2001). Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 86, 128-137.
15. Pugh LGCE (1964). Blood volume and haemoglobin concentration at altitudes above 18000 ft (5500 m). J Physiol 170, 344-354.
16. Reynafarje C, Lozano R & Valdivieso J (1959). The polycythemia of high altitude: Iron metabolism and related aspects. Blood 14, 433-455.
17. Wolfel EE, Groves BM, Brooks GA, Butterfield GE, Mazzeo RS, Moore LG et al. (1991). Oxygen transport during steady-state submaximal exercise in chronic hypoxia. J Appl Physiol 70, 1129-1136.